Keytruda

Merck's Keytruda snags I-O's first cervical cancer nod to back up HPV fighter Gardasil
Merck's Keytruda snags I-O's first cervical cancer nod to back up HPV fighter Gardasil
Fierce Pharma
Merck
Keytruda
FDA
cervical cancer
Flag link:
AbbVie's Humira, Merck's Keytruda and more: The top 10 drugs of 2024
AbbVie's Humira, Merck's Keytruda and more: The top 10 drugs of 2024
Fierce Pharma
Humira
AbbVie
Keytruda
Merck
Revlimid
Celgene
Opdivo
Bristol-Myers Squibb
Flag link:
ASCO18: 3 unanswered questions from oncology's largest conference
ASCO18: 3 unanswered questions from oncology's largest conference
Biopharma Dive
ASCO 2018
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
immunotherapy combinations
non-small cell lung cancer
Flag link:
ASCO: Merck and its new multibillion-dollar partners hone plans for marketing onslaught
ASCO: Merck and its new multibillion-dollar partners hone plans for marketing onslaught
Fierce Pharma
Merck
ASCO 2018
Keytruda
AstraZeneca
Eisai
Flag link:
More Good News For Keytruda - Shows Promising Results in Patients with Advanced Small Cell Lung Cancer
More Good News For Keytruda - Shows Promising Results in Patients with Advanced Small Cell Lung Cancer
CP Wire
Merck
Keytruda
small cell lung cancer
ASCO 2018
Flag link:
More Good News For Keytruda - Shows Promising Results in Patients with Advanced Small Cell Lung Cancer
Merck
Keytruda
small cell lung cancer
Flag link:
First Major Trial Of Keytruda For Prostate Cancer Shows It Works, But Only For A Minority Of Men
First Major Trial Of Keytruda For Prostate Cancer Shows It Works, But Only For A Minority Of Men
Forbes
Merck
Keytruda
advanced prostate cancer
ASCO 2018
Flag link:
Merck's Keytruda shown to extend lung cancer survival in two trials
Merck's Keytruda shown to extend lung cancer survival in two trials
Reuters
Merck
Keytruda
advanced squamous non-small cell lung cancer
ASCO 2018
Flag link:
Ahead of ASCO, BMS' Opdivo leads Merck's Keytruda in U.S. sales—but not for long, analyst predicts
Ahead of ASCO, BMS' Opdivo leads Merck's Keytruda in U.S. sales—but not for long, analyst predicts
Fierce Pharma
ASCO 2018
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Flag link:
5 Best-Selling Orphan Drugs in the U.S.
5 Best-Selling Orphan Drugs in the U.S.
Motley Fool
orphan drugs
Celgene
Revlimid
Roche
Rituxan
Teva Pharmaceutical
Copaxone
Opdivo
Bristol-Myers Squibb
Merck
Keytruda
Flag link:
Ahead of ASCO, Merck Touts Another Win for Lung Cancer Drug Combo
Ahead of ASCO, Merck Touts Another Win for Lung Cancer Drug Combo
Xconomy
Merck
Keytruda
advanced squamous non-small cell lung cancer
Flag link:
FDA warns of decreased survival in 2 studies of Keytruda, Tecentriq
FDA warns of decreased survival in 2 studies of Keytruda, Tecentriq
Biopharma Dive
FDA
clinical trials
oncologists
bladder cancer
Merck
Keytruda
Roche
Tecentriq
Flag link:
Syndax is hit with a setback during the ASCO preview round as lead drug flops in mid-stage study
Syndax is hit with a setback during the ASCO preview round as lead drug flops in mid-stage study
Endpoints
Syndax Pharma
HDAC inhibitors
entinostat
Keytruda
ASCO
Flag link:
5 takeaways from the first look at cancer's biggest conference
5 takeaways from the first look at cancer's biggest conference
Biopharma Dive
ASCO
Regeneron
cemiplimab
Keytruda
Opdivo
Merck
Bristol-Myers Squibb
Nektar
NKTR-214
Loxo Oncology
LOXO-292
Jounce Therapeutics
JTX-2011
Flag link:
Merck's Keytruda boosts response in hard-to-treat lung cancer
Merck's Keytruda boosts response in hard-to-treat lung cancer
Reuters
Merck
Keytruda
squamous cell lung cancer
Flag link:
Neon Therapeutics Treats First Patient in Ph Ib Trial Evaluating Personal Cancer Vaccine NEO-PV-01 Plus Keytruda/Chemo Combination
Neon Therapeutics Treats First Patient in Ph Ib Trial Evaluating Personal Cancer Vaccine NEO-PV-01 Plus Keytruda/Chemo Combination
CP Wire
Neon Therapeutics
NEO-PV-01
Merck
Keytruda
personalized medicine
Flag link:
OncoSec to combine ImmunoPulse device with Merck’s immunotherapy in breast cancer trial
OncoSec to combine ImmunoPulse device with Merck’s immunotherapy in breast cancer trial
Drug Delivery Business News
OncoSec Medical
Merck
ImmunoPulse IL-12
Keytruda
triple negative breast cancer
Flag link:
Merck Teams With Moderna To Take On One Of The Toughest Targets In Cancer
Merck Teams With Moderna To Take On One Of The Toughest Targets In Cancer
Forbes
Keytruda
Merck
Moderna
cancer vaccines
Flag link:
A tale of two lung cancer immunotherapies: Merck's Keytruda takes the reins
A tale of two lung cancer immunotherapies: Merck's Keytruda takes the reins
Medical Marketing and Media
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Flag link:
Incyte wipes out late-phase epacadostat program after pivotal failure of Keytruda combination
Incyte wipes out late-phase epacadostat program after pivotal failure of Keytruda combination
Fierce Biotech
Incyte
epacadostat
Keytruda
IDO inhibitors
Flag link:

Pages